MICHAEL THOMAS HENDERSON, the Chief Executive Officer of $APGE ($APGE), sold 2,868 shares of the company on 01-08-2025. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of their shares. Following this trade, they now own 1,309,487 shares of $APGE stock.
$APGE Insider Trading Activity
$APGE insiders have traded $APGE stock on the open market 31 times in the past 6 months. Of those trades, 2 have been purchases and 29 have been sales.
Here’s a breakdown of recent trading of $APGE stock by insiders over the last 6 months:
- MICHAEL THOMAS HENDERSON (Chief Executive Officer) has traded it 13 times. They made 0 purchases and 13 sales, selling 165,000 shares.
- CARL DAMBKOWSKI (Chief Medical Officer) has traded it 15 times. They made 0 purchases and 15 sales, selling 42,620 shares.
- MARK C. MCKENNA has traded it 2 times. They made 2 purchases, buying 20,000 shares and 0 sales.
- JANE HENDERSON (Chief Financial Officer) sold 6,000 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$APGE Hedge Fund Activity
We have seen 71 institutional investors add shares of $APGE stock to their portfolio, and 69 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 1,267,451 shares (+35.7%) to their portfolio in Q3 2024
- BRAIDWELL LP removed 748,816 shares (-31.3%) from their portfolio in Q3 2024
- WAYPOINT CAPITAL ADVISORS, LLC added 627,089 shares (+inf%) to their portfolio in Q3 2024
- JANUS HENDERSON GROUP PLC added 458,157 shares (+4018.9%) to their portfolio in Q3 2024
- POINT72 ASSET MANAGEMENT, L.P. added 438,036 shares (+162.7%) to their portfolio in Q3 2024
- DRIEHAUS CAPITAL MANAGEMENT LLC added 415,737 shares (+19.6%) to their portfolio in Q3 2024
- PARADIGM BIOCAPITAL ADVISORS LP added 371,817 shares (+112.7%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
